Stemming the Tide: Is Long-acting, IM Octreotide Injection Better than Standard of Care for Angiodysplasia-related GI Bleeding?

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Philip Okafor, MD, MPH discuss “Standard of care versus octreotide in angiodysplasia-related bleeding: a multicenter randomized control trial,” by Goltstein L, Grooteman KV, Bernts LH et al. Gastroenterology 2024; 155: 690-703):1649-1659.

Om Podcasten

A new monthly publication from the American College of Gastroenterology, Evidence-Based GI (EBGI) uses evidence-based methods to create abstracts and explain study results of new and important articles in the field of gastroenterology and hepatology. Listen as editors of EBGI discuss the articles they review and how the recommendations can be applied to your practice.